Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 EPS of ($0.01), $0.08 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $24 million versus the consensus estimate of $22.8 million.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.